Creon Drug Manufacturer
Available by prescription only, Creon® (pancrelipase) is a medication approved to treat pancreatic enzyme deficiency in adults, children, and infants. It comes as an extended-release capsule that is taken by mouth with each meal and snack.
Abbott Laboratories is the manufacturer of the drug. Because Creon is protected from generic competition by exclusivity rights that have not yet expired, companies are not allowed to make any generic versions of this medicine. However, after these rights expire in April 2013, companies may be allowed to manufacture a generic Creon product.
(For more information, click Creon. This resource provides more details on the manufacturer of this drug and also lists the available strengths of these extended-release capsules. A description of possible side effects, dosing guidelines, and safety precautions is also included.)